Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock by Weiss, S. L. et al.
Journal Articles Donald and Barbara Zucker School of MedicineAcademic Works
2015
Mitochondrial dysfunction in peripheral blood
mononuclear cells in pediatric septic shock
S. L. Weiss
M. A. Selak
F. Tuluc
J. Perales Villarroel
V. M. Nadkarni
See next page for additional authors
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Emergency Medicine Commons, and the Pediatrics Commons
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.
Recommended Citation
Weiss S, Selak M, Tuluc F, Perales Villarroel J, Nadkarni V, Deutschman C, Becker L. Mitochondrial dysfunction in peripheral blood
mononuclear cells in pediatric septic shock. . 2015 Jan 01; 16(1):Article 2786 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/2786. Free full text article.
Authors
S. L. Weiss, M. A. Selak, F. Tuluc, J. Perales Villarroel, V. M. Nadkarni, C. S. Deutschman, and L. B. Becker
This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/2786
Mitochondrial Dysfunction in Peripheral Blood Mononuclear 
Cells in Pediatric Septic Shock
Scott L. Weiss, MD1,2, Mary A. Selak, PhD2, Florin Tuluc, MD, PhD3, Jose Perales Villarroel, 
MD1,2, Vinay M. Nadkarni, MD, MS1, Clifford S. Deutschman, MS, MD4, and Lance B. 
Becker, MD2,5
1Division of Critical Care Medicine, Department of Anesthesia and Critical Care, The Children’s 
Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, 
PA, USA
2Center for Resuscitation Science, University of Pennsylvania Perelman School of Medicine, 
Philadelphia, PA, USA
3Flow Cytometry Research Core, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
4Department of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of 
Medicine, Philadelphia, PA, USA
5Department of Emergency Medicine, University of Pennsylvania Perelman School of Medicine, 
Philadelphia, PA, USA
Abstract
Objective—Mitochondrial dysfunction in peripheral blood mononuclear cells (PBMCs) has been 
linked to immune dysregulation and organ failure in adult sepsis but pediatric data are limited. We 
hypothesized that pediatric septic shock patients exhibit mitochondrial dysfunction within PBMCs 
which in turn correlates with global organ injury.
Design—Prospective observational study.
Setting—Academic pediatric intensive care unit (PICU).
Patients—Thirteen pediatric patients with septic shock and ≥2 organ failures and 11 PICU 
controls without sepsis or organ failure.
Interventions—Ex vivo measurements of mitochondrial oxygen consumption and membrane 
potential (ΔΨm) were performed in intact PBMCs on day 1–2 and day 5–7 of septic illness and in 
controls. The Pediatric Logistic Organ Dysfunction (PELOD) score, inotrope score, and organ 
failure-free days were determined from medical records.
Measurements and Main Results—Spare respiratory capacity (SRC), an index of 
bioenergetic reserve, was lower in septic PBMCs on day 1–2 (median 1.81, IQR 0.52–2.09 pmol 
O2/s/106 cells) compared to controls (5.55, 2.80–7.21; p=0.03). SRC normalized by day 5–7. 
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Septic patients on day 1–2 exhibited a higher ratio of LEAK to maximal respiration than controls 
(17% versus <1%, p=0.047) with normalization by day 5–7 (1%, p=0.008), suggesting 
mitochondrial uncoupling early in sepsis. However, septic PBMCs exhibited no differences in 
basal or ATP-linked oxygen consumption or ΔΨm. Oxygen consumption did not correlate with 
PELOD, inotrope score, or organ failure-free days (all p>0.05). While there was a weak overall 
association between ΔΨm on day 1–2 and organ failure-free days (Spearman’s ρ=0.56, p=0.06), 
septic patients with normal organ function by day 7 exhibited higher ΔΨm on day 1–2 compared 
to patients with organ failure for >7 days (p=0.04).
Conclusions—Mitochondrial dysfunction was present in PBMCs in pediatric sepsis, evidenced 
by decreased bioenergetic reserve and increased uncoupling. Mitochondrial membrane potential, 
but not respiration, was associated with duration of organ injury.
Keywords
mitochondria; bioenergetic reserve; energy failure; sepsis; critically ill children
INTRODUCTION
The sepsis syndrome is a leading cause of morbidity and mortality in pediatric patients (1). 
Despite antibiotics and early goal-directed therapy, 20–40% of children with sepsis develop 
organ injury requiring hospitalization in an intensive care unit (2). For critically ill children 
with sepsis-induced organ injury, therapy remains limited to supportive care and mortality is 
between 15–50% (2–4). In the current era, most of these deaths are related to multiple organ 
dysfunction syndrome (MODS) (2) or secondary infection (5).
Mitochondrial dysfunction has been implicated in the pathogenesis of organ injury and 
immune suppresion in adult sepsis but direct mitochondrial measurements in pediatric sepsis 
are limited (6). Under normal conditions, oxygen consumption through the mitochondrial 
electron transport system (ETS) is used to drive ATP production. Failure of mitochondria to 
efficiently use oxygen to sustain ATP production results in an energy deficit that can impair 
cell, and ultimately, organ function (7). Mitochondrial dysfunction can be detected by 
measuring oxygen consumption and mitochondrial membrane potential (ΔΨm). Oxygen 
consumption reflects mitochondrial oxidative respiration and measures using inhibitors and 
uncouplers are well standardized (8, 9). The spare respiratory capacity (SRC), in particular, 
reflects the ability of the ETS to keep pace with an increase in energy demand (8, 10, 11). 
ΔΨm is the difference in electrical potential across the inner mitochondrial membrane and 
reflects the ability of the ETS to maintain the proton gradient that drives ATP production.
Mitochondrial abnormalities are evident in heart, kidney, and liver following septic insults 
in animal models (12–14). However, direct evidence for mitochondrial dysfunction in 
human studies is limited, largely due to the impracticality of tissue biopsies in critically ill 
patients (15, 16). Several studies have shown that alterations in mitochondrial respiration in 
peripheral blood mononuclear cells (PBMCs)—monocytes and lymphocytes--are associated 
with disease severity, immune suppression, and mortality (17–21). Under quiescent 
conditions, PBMCs rely more on mitochondrial respiration than glycolysis to meet 
metabolic demands and exhibit a substantial SRC (22–24). These data suggest promise for 
Weiss et al. Page 2
Pediatr Crit Care Med. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
using PBMCs to gauge systemic mitochondrial derangements in vital organs and to impart 
insight into a possible mechanism of sepsis-induced immunosuppression (25–27). At 
present, there are no data on mitochondrial dysfunction in PBMCs from children with 
sepsis-induced MODS. Maturational differences in the response to sepsis (28) and age-
related changes in mitochondrial biology preclude direct extrapolation of adult data to 
younger patients (29).
We sought to determine if measurable defects in mitochondrial dysfunction occur within 
PBMCs and correlate with severity and duration of organ injury in pediatric septic shock. 
We hypothesized that mitochondrial oxygen consumption and ΔΨm are decreased in 
PBMCs from septic pediatric patients and correlate with severity and duration of organ 
injury.
METHODS
This prospective, observational study was performed in the pediatric intensive care unit 
(PICU) at The Children’s Hospital of Philadelphia from July 2012 to September 2013. The 
study was approved by the Institutional Review Board and informed consent was obtained.
Study Population
All patients ≤ 18 years-old admitted to the PICU who met criteria for septic shock and 
MODS as defined by the International Pediatric Sepsis Consensus Conference (30) were 
screened for eligibility. Consensus criteria define septic shock as 1) ≥ 2 age-based systemic 
inflammatory response syndrome criteria, 2) confirmed or suspected invasive infection, and 
3) cardiovascular dysfunction (hypotension, need for vasoactive agent, or impaired 
perfusion despite 40 mL/kg intravenous fluid). MODS, defined as at least two concurrent 
dysfunctional organ systems (30), was required to be present for at least 12 hours. To reduce 
the likelihood that organ dysfunction was solely a consequence of inadequate resuscitation, 
only patients who achieved an age-appropriate minimum systolic blood pressure within 24 
hours of sepsis recognition for at least four consecutive hours were enrolled. PICU patients 
without evidence for sepsis, infection, or organ dysfunction for at least 48 hours were 
enrolled as controls. Exclusion criteria were weight <5 kg (due to limitations of blood 
collection), white blood cell count <0.5×103/μL, a known mitochondrial disorder, pre-
existing chronic kidney disease or liver failure, cyanotic heart disease, surgery in the 
preceding 24 hours (other than for infectious source control), support with hemodialysis, 
hemofiltration, and/or extracorporal membrane oxygenation, and treatment with coenzyme 
Q, arginine, carnitine, or cyclosporine (due to direct mitochondrial effects).
Data Collection
Data were abstracted from the medical record onto a standardized form. Variables included 
demographics, comorbid conditions, source of infection, laboratory and microbiology 
results, use of vasoactive infusions, mechanical ventilation, antimicrobials, corticosteroids, 
and insulin, length of stay, and vital status. Organ dysfunction was monitored for 28 days 
after sepsis recognition (30). Duration of organ dysfunction was measured by the number of 
organ failure-free days from study enrollment to day 28, with death corresponding to zero 
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organ failure-free days (30). We compared patients with rapid recovery (within 7 days) 
versus prolonged duration (greater than 7 days) of organ dysfunction based on previous 
reports of the timing of maximal organ dysfunction (31) and the median time to complete 
resolution of organ dysfunction in pediatric septic shock (3). Severity of illness was 
determined by the Pediatric Risk of Mortality (PRISM)-III (32), Pediatric Logistic Organ 
Dysfunction (PELOD) (33), and inotrope scores (34).
Blood collection
A 4.5 mL (patients ≤ 10 kg) or 6 mL (>10 kg) blood specimen was collected as soon as 
possible after consent was obtained but no later than 48 hours after sepsis recognition (or 
study enrollment for controls; referred to as day 1–2 specimen). For patients with sepsis, a 
second blood sample was collected on study day 5–7. Assays for mitochondrial dysfunction 
were performed on fresh samples immediately after blood collection.
Mitochondrial Oxygen Consumption
PBMCs were isolated from citrated whole blood by density gradient centrifugation. Blood 
samples were diluted 1:1 using a balanced salt solution (anhydrous D-glucose 5.5mM, 
CaCl2 5 mM, MgCl2 0.98 mM, KCl 5.4 mM, TRIS 145 mM, and NaCl 140 mM with pH 
adjusted to 7.6) and layered on top of Ficoll-Paque PLUS (density 1.077 g/mL; Amersham 
Biosciences, Piscataway, NJ). The sample was centrifuged at 400g for 40 minutes at 20–
25°C. The lymphocyte/monocyte layer at the interface was gently aspirated and centrifuged 
again at 1800g for five minutes. The PBMC pellet was then resuspended in Hank’s balanced 
salt solution (pH 7.40) containing 5.5 mM glucose, 1mM pyruvate, and 10 mM HEPES. Cell 
counts were performed using trypan blue exclusion (Countess, Life Technologies, Grand 
Island, NY) with >90% viability.
Intact PBMCs were placed in a 2 mL chamber at a final concentration of 1–2 × 106 
cells/mL. Measurements of oxygen consumption were performed at 37°C in a high-
resolution oxygraph (Oxygraph-2k Oroborus Instruments, Innsbruck, Austria). Oxygen flux 
(in pmol O2/s/106 cells), which is directly proportional to oxygen consumption, was 
recorded continuously using DatLab software 4.3 (Oroborus Instruments, Innsbruck, 
Austria) as shown in Figure 1 (9). After basal oxygen consumption was recorded for 10–20 
minutes, the ATP-synthase inhibitor oligomycin (1 μg/mL) was added to induce a state 4-
like respiration independent of mitochondrial ATP production in which oxygen consumption 
was primarily due to leakage of protons across the inner mitochondrial membrane (LEAK, 
abbreviated as L). In this standard protocol, it is assumed that the presence of glucose in the 
polarographic assay buffer provides ample substrate to support increased cellular flux 
through glycolysis and, thus, prevents critical ATP deprivation during the short-term 
incubation (~10–15 minutes) with oligomycin. Maximal oxygen consumption through the 
electron transport system was obtained by stepwise titration (1–2 μM) of the uncoupler 
carbonyl cyanide m-chlorophenylhydrazone (CCCP) until no further increase in oxygen 
consumption was detected (ETSmax, abbreviated as E). Mitochondrial respiration was then 
inhibited by adding the ETS complex IV inhibitor, sodium azide, in 5–10 mM increments 
until no further decrease in oxygen consumption was observed. The residual oxygen flux 
following optimal azide inhibition reflects non-mitochondrial oxygen consumption and was 
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subtracted from other respiration values. Oxygen consumption supporting mitochondrial 
ATP synthesis (ATP-linked respiration) was calculated as basal minus LEAK respiration. 
Spare respiratory capacity (SRC), a measure of mitochondrial reserve available for cells to 
produce energy in response to a stress-induced increase in metabolic demand, was calculated 
as ETSmax minus basal respiration. SRC indicates how close to its bionenergetic limit a cell 
is operating (8). The ratio of LEAK to ETSmax (L/E or LEAK flux control ratio) is an index 
for uncoupling of mitochondrial oxygen consumption from ATP synthesis (9).
Mitochondrial Membrane Potential (ΔΨm)
ΔΨm was measured using MitoTracker Red CMXRos (MTR; Molecular Probes, Oregon). 
MTR is oxidized to a fluorescent state in live cells and is sequestered within the 
mitochondria in a manner directly related to ΔΨm. MitoTracker Green FM dye (MTG; 
Molecular Probes, Oregon) was used to normalize ΔΨm to mitochondrial mass (35). A 50 
μL sample of whole blood collected on EDTA was incubated with 5 μL of the CD45-Alexa 
Fluor 647 antibody for 15 minutes in a dark room at room temperature. Separate samples 
were then diluted 1:1000 in Hank’s balanced salt solution and incubated with MTR (100 nM 
for 45 minutes) or MTG (100 nM for 30 minutes) at 37°C. Using an Accuri C6 flow 
cytometer (BD Biosciences, San Jose, CA), the fluorescence emitted by MTR and MTG was 
measured in the FL-3 channel (670 nm longpass) and FL-1 channel (530/30 nm), 
respectively. The 488 nm blue laser was used for excitation and an acquisition threshold was 
set to exclude Alexa Fluor 647-negative events (i.e., red blood cells and platelets). The ratio 
of median fluorescence intensities of MTR and MTG was calculated using FlowJo (Treestar, 
Ashland, OR).
Statistical Analysis
Analyses were performed using STATA (Version 12.1, College Station, TX). Data are 
presented as medians with interquartile ranges (IQR) for continuous variables and 
frequencies with percentages for categorical variables. Comparisons between septic and 
control patients were performed using the Wilcoxon rank sum test and changes in 
mitochondrial dysfunction over time were analyzed using the Wilcoxon sign rank test. 
Categorical variables were compared using Fisher’s exact test. The association of 
mitochondrial dysfunction with organ failure-free days and severity of illness scores were 
analyzed with Spearman’s rank-correlation test. Statistical significance was defined as a p-
value < 0.05.
RESULTS
Of 175 patients screened, 52 (30%) met criteria for septic shock and MODS. Fifteen (54%) 
of those approached consented to study participation (Figure 2). Two patients were excluded 
due to laboratory processing errors that precluded measurement of mitochondrial 
dysfunction, leaving 13 septic patients for analysis. Eleven control patients were also 
enrolled. Septic and control patients were similar in age (median, IQR 6.4, 2.2–12.9 versus 
8.0, 3.7–15.6 years; p=0.67), sex (male 31% versus 55%; p=0.41), and race (White 38% 
versus 46%, Black 31% versus 36%; p=0.77). PRISM-III scores were higher in septic (14, 
7–18) than control (2, 0–2) patients (p=0.002). Table 1 shows the characteristics of the 
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septic and control patients. Table 2 shows characteristics and severity of illness of the 
patients at the time of blood sampling. The normal values for lactate and central venous 
oxygen saturation indicate that septic patients were appropriately resuscitated prior to study 
enrollment.
As shown in Figure 3, PBMCs from septic patients on day 1–2 exhibited no differences 
from controls in basal (2.53, 2.03–2.95 versus 1.81, 0.9–3.07 pmol O2/s/106 cells; p=0.62), 
LEAK (0.56, 0.15–0.75 versus 0, 0–0.03 pmol O2/s/106 cells; p=0.10), or ATP-linked 
respiration (2.04, 1.05–3.49 versus 2.52, 1.61, 3.13 pmol O2/s/106 cells; p=0.74). ETSmax 
oxygen consumption trended lower in sepsis but this was not significant (4.30, 2.99–5.27 
versus 7.50, 4.07–11.21 pmol O2/s/106 cells; p=0.10). SRC, however, was significantly 
lower in PBMCs from septic patients on day 1–2 compared to controls (1.81, 0.52–2.09 
versus 5.55, 2.80–7.21 pmol O2/s/106 cells; p=0.03). In addition, the ratio of LEAK to 
ETSmax (L/E) was significantly higher in septic patients on day 1–2 (17%) versus controls 
(<1%, p=0.047) and returned toward baseline by days 5–7 (p=0.008), suggesting partial 
mitochondrial uncoupling in early sepsis (Figure 4). Although we excluded some 
pharmacologic agents that strongly target mitochondria, three septic patients were treated 
with the mitochondrial inhibitor valproic acid. A sensitivity analysis excluding these three 
subjects paralleled the overall results with SRC trending lower in sepsis patients on day 1–2 
versus controls (1.90, 0.76–2.53 versus 5.55, 2.80–7.21 pmol O2/s/106 cells; p=0.06) and 
L/E trending higher in sepsis patients on day 1–2 versus controls (12% versus <1%, p=0.07). 
Given the range of medications with potential effects on mitochondrial function, we list all 
medications prescribed on each study day in Supplemental Table 1.
Septic PBMCs exhibited no change in basal, ATP-linked, or ETSmax oxygen consumption 
over time (Figure 3). However, SRC increased as septic patients recovered organ function 
(decrease in PELOD in Table 2), showing no difference from control values by day 5–7.
Measures of PBMC mitochondrial respiration, including SRC and LEAK, did not correlate 
with organ failure-free days, inotrope score, or PELOD (p>0.05 for all pair-wise 
correlations). However, SRC was inversely associated with ScvO2 in septic patients on both 
days 1–2 (ρ= −0.71, p=0.07) and 5–7 (ρ= −0.67, p=0.049), suggesting lower systemic 
oxygen consumption in patients with diminished capacity for PBMC mitochondrial 
respiration.
There were no differences in ΔΨm, normalized to mitochondrial mass, between controls and 
septic patients on day 1–2 or day 5–7 (Figure 5A). Within the septic group, there was a weak 
linear association between ΔΨm and organ failure-free days (ρ=0.56, p=0.06). Septic 
patients with recovery of organ function by day seven exhibited a higher ΔΨm on day 1–2 
(MTR/MTG ratio 0.62, IQR0.47, 0.82) compared to septic patients with organ dysfunction 
for more than seven days (0.32, IQR 0.14–0.35; p=0.04) and controls (0.19, IQR 0.15–0.37; 
p=0.02; Figure 5B).
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DISCUSSION
Our data is the first to demonstrate that mitochondrial dysfunction is evident in PBMCs 
from critically ill children with septic shock and MODS. We found that mitochondrial 
bioenergetic reserve, indicated by spare respiratory capacity, was significantly diminished in 
PBMCs early in pediatric sepsis with a possible increase in mitochondrial uncoupling. 
Although mitochondrial respiration was not associated with the severity or duration of organ 
dysfunction in this small sample, septic patients with recovery from organ dysfunction by 
day seven exhibited a higher PBMC ΔΨm relative to mitochondrial mass compared to septic 
patients with prolonged organ dysfunction.
Decreased SRC indicates mitochondrial dysfunction that may not be apparent under basal 
conditions but becomes manifest as stress and ATP demand increases (8). SRC is a critical 
determinant of cell survival and function in a variety of cell types (10), including immune 
cells (11). If SRC is not sufficient to meet a stress-induced increase in metabolic demand (as 
is present in sepsis), cells may experience an energetic exhaustion that can lead to organ 
dysfunction. In the case of PBMCs, this may present clinically as immune dysregulation or 
suppression. Prior studies have shown that reduced mitochondrial respiration in PBMCs is 
associated with immunosuppression in adult sepsis (18) and in hemorrhagic shock (26). The 
combined observations in this study that basal oxygen consumption was maintained while 
SRC was diminished suggests that PBMCs are respiring near maximal levels during early 
sepsis in order to maintain ATP-linked oxygen consumption and other mitochondrial 
functions. Although a metabolic transition from oxidative phosphorylation to glycolysis 
upon PBMC activation (particularly in lymphocytes) could help to preserve overall cellular 
ATP production, oxidative phosphorylation remains critical to PBMC survival (23, 24) and 
these immune cells appear to be dangerously close to the point of mitochondrial bioenergetic 
failure early in pediatric sepsis.
Our pediatric data agree with several prior studies in adult sepsis that have reported 
decreased mitochondrial oxygen consumption in PBMCs from septic adults (18–20). For 
example, Belikova et al. found that maximal oxygen consumption in the presence of 
uncoupler was decreased (though SRC was not explicitly calculated) and the fraction of 
LEAK respiration was increased compared to healthy controls (18). In contrast to these 
findings, however, Sjovall et al. demonstrated a progressive increase in basal and maximal 
respiration in adult PBMCs on day 1–2 through day 6–7 of sepsis compared to healthy 
controls (21). These contradictory findings may stem from methodological variability 
between studies. For example, we isolated PBMCs in respiration buffer solution while 
Sjovall et al. resuspended cells in plasma (21). If intracellular mitochondrial substrates (e.g., 
fatty acids, NADPH) are limited in sepsis, the lack of available plasma-derived substrates 
could account for the decrease in maximal oxygen consumption we observed in septic 
PBMCs compared to the increase observed in the study by Sjovall et al. Alternatively, prior 
studies have shown that septic plasma increases mitochondrial uncoupling, which should 
decrease SRC (36, 37). Because this effect appears reversible (18), resuspension of PBMCs 
in a standard buffer provides a more direct measure of intrinsic PBMC mitochondrial 
function as well as reduces variability in plasma factors between patients (e.g, different 
medications). However, as PBMCs function in their plasma environment, it is not clear if 
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resuspension in plasma more accurately approximates in vivo PBMC mitochondrial 
function.
We also found that the proportion of maximal mitochondrial respiration attributable to 
LEAK increased from <1% in controls to 17% during early sepsis. An increase in LEAK 
respiration suggests that mitochondrial oxygen consumption has become uncoupled from 
ATP synthesis, rendering oxidative phosphorylation less efficient. However, less well-
coupled mitochondrial also produce less reactive oxygen species and thus could be a 
protective mechanism to limit oxidative damage at the expense of a small loss of energy (8). 
While this finding is suggestive of an increase in mitochondrial uncoupling, it should be 
noted that the L/E ratio may also increase in normally coupled mitochondria if the ETSmax is 
diminished as was the trend in our study. Furthermore, prior studies using PBMCs from 
healthy animals and human adults have reported L/E ratios ranging 1–10% (18, 21, 26, 38). 
The L/E ratio of ~1% observed in our PICU controls was at the lower end of this range, 
which could reflect either tightly coupled PBMC mitochondria in non-septic PICU patients 
or the challenge of accurately measuring LEAK in cases where these values approach 
residual oxygen consumption.
We were surprised to find no difference in ΔΨm between septic and control patients since 
reduced ΔΨm has been reported in PBMCs from adult patients with sepsis (17, 19). Several 
possible explanations may account these divergent findings. First, as the one nonsurvivor 
had the lowest MTR/MTG ratio in our cohort, differences in ΔΨm may have been more 
apparent if mortality was higher. Second, it has been proposed that MTG itself may be 
affected by changes in ΔΨm leading to inaccurate measures of ΔΨm using the MTR/MTG 
ratio (39). While we did not see large changes in MTG with purposeful dissipation of ΔΨm 
in preliminary work (data not shown), we cannot rule out this possibility. Third, relying on 
the median MTR/MTG value may fail to discern important changes in ΔΨm in subgroups of 
septic patients. In support of this explanation, we found that patients with full recovery of 
organ dysfunction within seven days exhibited the highest MTR/MTG ratio. A rise in 
MTR/MTG may reflect either an increase in ΔΨm or a decrease in mitochondrial mass. 
Mitochondrial hyperpolarizaton (increased ΔΨm) protects against formation of the 
mitochondrial transition pore and thus reduces apoptosis. Insufficient mitophagy of damaged 
mitochondria has been shown to contribute to organ injury in critical illness (40). Thus, 
either mitochondrial hyperpolarization (higher MTR) or reduced mitochondrial mass (lower 
MTG) could potentially underlie the rapid recovery in the subset of patients with highest 
MTR/MTG ratio.
We did not find an association between PBMC mitochondrial respiration and severity or 
duration of organ failure in our pediatric patients. Two prior studies using PBMCs in adult 
sepsis reported an association between reduced mitochondrial respiration and degree of 
organ injury (19, 20) while a third did not find an association with mortality (21). Given 
evidence for mitochondrial injury in pre-clinical and adult studies, it is unlikely that vital 
organ mitochondria remain unaffected in pediatric sepsis. Rather, PBMCs may be an 
inadequate biomarker of mitochondrial dysfunction in other organs (22). We previously 
reported strong correlation between mitochondrial dysfunction measured in PBMCs and 
heart, liver, and kidney cells early in a hemorrhagic shock model, but noted substantial 
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variability in mitochondrial respiration across organs after resuscitation (27). Moreover, use 
of a relatively crude mix of PBMCs provides only a weighted average of bioenergetic 
activity across diverse cell types with known differences in both glycolytic and 
mitochondrial function. More research is needed to determine if specific leukocyte subsets 
could provide a stronger clinical biomarker for mitochondrial dysfunction in other organ 
systems.
There are several limitations to this study. First, minor but significant changes in 
mitochondrial function would not have been detected in this small study. Our selection of 
PICU controls versus healthy children may also have biased results toward the null if PBMC 
mitochondrial function is similarly inhibited by non-septic illness. Second, although we 
excluded some known pharmacological agents that target mitochondria, given the small 
sample size, we were not able to control for other potential medication effects on 
mitochondrial function. However, a sensitivity analysis excluding patients receiving valproic 
acid yielded similar results to the overall analysis. Second, we normalized measures of 
oxygen consumption to cell number but not mitochondrial content. A recent study 
demonstrated that changes in mitochondrial content may be an important cause of altered 
cellular respiration (21). Third, because we were interested in the occurrence of 
mitochondrial dysfunction in patients with persistent MODS despite adequate resuscitation, 
we did not determine if peak mitochondrial injury may be antecedent to or concurrent with 
shock onset. In addition, although we excluded patients with prolonged hypotension in order 
to limit the impact of inadequate resuscitation on mitochondrial measurements, this may 
have also excluded the most severely ill patients. Finally, because we considered PBMCs all 
together, we do not have information about differences in mitochondrial dysfunction within 
subpopulations of immune cells (e.g., monocytes, T- and B-lymphocytes). Further insight 
into the complete bioenergetic profile of distinct leuckocyte subests may also be elucidated 
by studying these cells under both resting and immunostimulated conditions, similar to 
provocative assessments of immune function (5).
CONCLUSIONS
Mitochondrial dysfunction, indicated by a decreased spare respiratory capacity and 
increased uncoupling, occurs in PBMCs from critically ill children with septic shock and 
MODS. PBMCs may be operating at or near their maximum oxidative respiratory capacity 
early in pediatric septic shock, leaving these cells vulnerable to stress, bioenergetic 
exhaustion, and dysfunction. Changes in PBMC mitochondrial membrane potential (ΔΨm) 
relative to mitochondrial mass, but not respiration, were associated with duration of organ 
failure. Future studies using PBMCs could provide insight into the linkages between 
mitochondrial dysfunction, immune dysregulation, and organ injury in pediatric sepsis.
Supplemental Table 1: Medications prescribed to patients at time of blood sampling
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Figure 1. 
Representative tracing of oxygen consumption measured in intact PBMCs. The solid black 
line shows the amount of oxygen present in the chamber over time. The dashed black line 
shows the rate of oxygen consumption (oxygen flux). After measuring basal oxygen 
consumption, the ATP-synthase inhibitor oligomycin is added to obtain LEAK. Then, to 
measure maximal oxygen consumption, the uncoupler carbonyl cyanide m-
chlorophenylhydrazone (CCCP) is repeatedly added until no further increase in oxygen 
consumption is detected. Residual, non-mitochondrial respiration is obtained by adding the 
ETS complex IV inhibitor, sodium azide, which is then subtracted from the other 
measurements. Finally, ATP-linked oxygen consumption is calculated as basal minus LEAK 
and spare respiratory capacity (SRC, double-headed arrow) is calculated as maximal minus 
basal oxygen consumption.
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Figure 2. 
Patient screening and study enrollment.
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Figure 3. 
Mitochondrial oxygen consumption was measured in PBMCs. Septic shock reduces spare 
respiratory capacity (SRC) but not basal, LEAK, or ATP-linked oxygen consumption in 
PBMCs on day 1–2. By day 5–7, SRC normalized but ATP-linked oxygen consumption was 
decreased below control values. Data are presented in box plot analysis with the central line 
indicating the median and the white (control) and gray (sepsis) boxes indicating the 
interquartile range. *p=0.03, **p=0.02
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Figure 4. 
LEAK flux control ratio. The ratio of LEAK to ETSmax respiration (L/E) is an index for 
uncoupling of mitochondrial oxygen consumption from ATP synthesis. Each bar represents 
the median maximal oxygen consumption through the ETS (ETSmax) obtained by stepwise 
titration of uncoupler. The black portion of each bar is the L/E ratio, or proportion of 
maximal respiration not inhibited by oligomycin (called LEAK respiration). The L/E ratio 
was highest in septic patients on day 1–2, suggesting partial mitochondrial uncoupling early 
in pediatric sepsis.
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Figure 5. 
Assessment of mitochondrial membrane potential (ΔΨm) in PBMCs. MitoTracker Red 
(MTR) indicates ΔΨm and MitoTracker Green (MTG) indicates mitochondrial mass. A, 
ΔΨm, normalized to mitochondrial mass, was not different between controls and septic 
patients on day 1–2 or day 5–7. Data are presented in box plot analysis with the central line 
indicating the median and the white (control) and gray (sepsis) boxes indicating the 
interquartile range. B, In septic patients, MTR/MTG on day 1–2 weakly correlated with 
organ failure-free days (dashed line, ρ=0.56, p=0.06). Control patients cluster at 28 organ 
failure-free days because none had organ dysfunction during the study period. MTR/MTG 
was higher in septic patients with a short duration of organ failure ≤7 days (i.e., more organ 
failure-free days, shaded region) compared to septic patients with organ failure duration >7 
days (p=0.04) and controls (p=0.02).
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Table 2
Clinical features of patients at time of blood sampling
Controls Sepsis (Day 1–2) Sepsis (Day 5–7)
PELOD score 0 (0–0) 11 (10–11) 1 (0–10)
Inotrope score 0 (0–0) 9 (5–13) 7 (3–11)
WBC (thous/μL) 9.4 (7.9–10.7)b 9.8 (8.6–11.5) 9.8 (8.1–11.4)
 PBMCs (per μL)a 1905 (1208–2765)b 1615 (1372–2700) 2958 (2187–3990)
 Lymphocytes (per μL) 1270 (900–2370)b 1131 (801–1914) 2156 (1768–3306)
 Monocytes (per μL) 434 (395–635)b 448 (285–696) 696 (486–1048)
Lactate (mmol/L) n/a 0.9 (0.7–1.3) 0.9 (0.9–1.6)
ScvO2 (%) n/a 75 (71–83) 76 (70–80)
Corticosteroids, n (%) 2 (18) 5 (38) 4 (40)
Insulin, n (%) 1 (9) 0 0
Aminoglycoside, n(%) 0 0 0
Values are median (interquartile range), unless otherwise noted
PELOD; Pediatric Logistic Organ Dysfunction; WBC, white blood cell count; PBMCs; peripheral blood mononuclear cells; ScvO2; central venous 
oxygen saturation; n/a, data not available
aAbsolute number of lymphocytes and monocytes on complete blood count
bComplete blood count data available from only 9 of the 11 control patients
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